2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk

The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

Saved in:

Bibliographic Details
Main Authors:	Francois Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G. De Backer, Victoria Delgado, Brian A. Ference, Ian M. Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J. Richter, Marc S. Sabatine, Marja-Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2020-06-01
Series:	Российский кардиологический журнал
Subjects:	guidelines dyslipidaemias cholesterol triglycerides low-density lipoproteins high-density lipoproteins apolipoprotein b lipoprotein(a) lipoprotein remnants total cardiovascular risk treatment (lifestyle) treatment (drugs)
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/3826
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS
by: Alberico L. Catapano, et al.
Published: (2017-06-01)

VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
by: V. А. Korneva, et al.
Published: (2017-03-01)

Impact of COVID-19 on pro- and antiatherogenic lipoproteins (cross-sectional population study)
by: P. S. Sadovnikov, et al.
Published: (2024-10-01)

Effects of a competitive season on the plasma lipid profile of soccer players
by: Santo Marsigliante, et al.
Published: (2025-05-01)

Assessment of the Utilization of Lipoprotein (a) and its Relationship with Cardiovascular Outcomes: A Retrospective Cohort Study from a Public Hospital in New York City
by: Maisha Maliha, et al.
Published: (2025-01-01)

Analysis of risk factors for aortic stenosis in patients with familial hypercholesterolemia
by: V. A. Korneva, et al.
Published: (2025-02-01)

Association Between Non-HDL to HDL Cholesterol Ratio (NHHR) and Psoriasis in Adults: A Cross-Sectional Study Using 2009–2014 Data
by: Jiang Y, et al.
Published: (2024-11-01)

RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME
by: N. V. Perova, et al.
Published: (2015-09-01)

Antibodies to low-density lipoproteins modified by malonic dialdehyde: contents in blood and role in atherogenesis
by: A. A. Ivanova, et al.
Published: (2025-01-01)

Association between remnant cholesterol and low-density lipoprotein cholesterol discordance and type 2 diabetes or prediabetes: results from NHANES
by: Yijing Xin, et al.
Published: (2025-07-01)

Hypertriglyceridemia — current status of the problem. Part I: risks, physiology and pathophysiological aspects, classification and diagnostic problems
by: A. A. Semenkin, et al.
Published: (2025-02-01)

Protective Effect of Thyme Extract on Albino Rats Exposed to Paraquat
by: Nazar M. Shareef Mahmood
Published: (2022-01-01)

Protective Effect of Thyme Extract on Albino Rats Exposed to Paraquat
by: Nazar M. Shareef Mahmood
Published: (2022-01-01)

Protective Effect of Thyme Extract on Albino Rats Exposed to Paraquat
by: Nazar M. Shareef Mahmood
Published: (2022-01-01)

Protective Effect of Thyme Extract on Albino Rats Exposed to Paraquat
by: Nazar M. Shareef Mahmood
Published: (2022-01-01)

Age and gender characteristics of dyslipidemia prevalence among the Bishkek city residents
by: T. M. Murataliev, et al.
Published: (2019-04-01)

HDL from 36-h fasted participants potently promotes efflux of cholesteryl ester from activated microglia
by: Joanne K. Agus, et al.
Published: (2025-08-01)

EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION
by: R. D. Kurbanov, et al.
Published: (2015-09-01)

Relationship between the white blood cell count and some lipid profile parameters in cancer patients with myocardial infarction
by: E. G. Skorodumova, et al.
Published: (2024-08-01)

Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study)
by: R. G. Oganov, et al.
Published: (2012-08-01)

Serum uric acid to high-density lipoprotein cholesterol ratio is associated with stroke in the elderly: a population-based study
by: Qingsong Jiang, et al.
Published: (2025-08-01)

The predictive value of neutrophil to high-density lipoprotein cholesterol ratio in early pregnancy for gestational diabetes based on nomogram
by: Yuehan Ma, et al.
Published: (2025-08-01)

HDL-C and visceral adipose tissue as combined predictors of visceral fat changes following laparoscopic sleeve gastrectomy
by: Yilan Sun, et al.
Published: (2025-08-01)

China diverges from global trends in a 30 year comparative analysis and future projections of ischemic heart disease burden attributable to high LDL cholesterol
by: Jianing Liu, et al.
Published: (2025-07-01)

Helicobacter pylori infection increases the risk of dyslipidemia in Chinese non-obese and non-diabetic population from the perspective of age category: a retrospective cross-sectional study
by: Huihui Shang, et al.
Published: (2025-07-01)

Studying Myostatin as a Diagnostic Indicator in Sera of Iraqi Women with Metabolic Syndrome
by: Riyam Hussein Assaf, et al.
Published: (2024-05-01)

Analysis of macrophage transcriptome in atherogenesis
by: M. V. Kubekina, et al.
Published: (2019-03-01)

Effect of phytocomposition on dyslipidemia in patients with SARS-CoV-2 infection at the health resort stage of treatment
by: I. A. Yatskov, et al.
Published: (2025-03-01)

Synergistic effects of serum albumin and HDL cholesterol concentrations on serum oxidized LDL cholesterol concentration in obese individuals with normal glycoregulation and patients with type 2 diabetes mellitus
by: Pejin Radoslav, et al.
Published: (2025-01-01)

Low-density lipoprotein cholesterol mediates the causal association between systemic lupus erythematosus and asthma: a mediation mendelian randomization study
by: Hui Yin, et al.
Published: (2025-07-01)

Association of baseline remnant cholesterol independent of LDL-cholesterol with newly diagnosed diabetes in the Chinese population
by: Yulu Yang, et al.
Published: (2024-10-01)

Remnant–to–LDL cholesterol discordance as a predictor of thromboembolic events in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF project III (MAFP-III) cohort study
by: Eva Soler-Espejo, et al.
Published: (2025-07-01)

Familial Hypercholesterolemia in Children. The Current State of the Problem
by: Dinara I. Sadykova, et al.
Published: (2023-07-01)

Hyperhomocysteinemia in men population of Novosibirsk
by: Yu. P. Nikitin, et al.
Published: (2007-08-01)

CENTRALISED SURVEY ON THE UNDERTREATMENT OF THE HYPERCHOLESTEROLEMIA IN RUSSIA (CEPHEUS)
by: S. A. Boytsov, et al.
Published: (2013-08-01)

Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01)

Effects of six weeks of aerobic training on level of IL-10 and lipid profile in obese women.
by: علی بنایی فر, et al.
Published: (2013-04-01)

Role of blood cholesterol transport system disturbances in atherosclerosis development in rheumatoid arthritis
by: T. V. Popkova, et al.
Published: (2007-10-01)

Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis
by: A. V. Susekov, et al.
Published: (2009-12-01)

Prevalence and penetrance of pathogenic and likely pathogenic LDLR and APOB gene variants linked to familial hypercholesterolemia and increased risk of ischemic heart disease
by: I. K. Dzhumaniiazova, et al.
Published: (2025-08-01)

-->